Sfoglia per Autore
Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models
2024-01-01 Stoppa, Ian; Dianzani, Chiara; Clemente, Nausicaa; Bozza, Annalisa; Bordano, Valentina; Garelli, Sara; Cangemi, Luigi; Dianzani, Umberto; Battaglia, Luigi
A New Blend of Litsea cubeba, Pinus mugo, and Cymbopogon winterianus Essential Oil Active as an Anti-tyrosinase Ingredient in Topical Formulations
2024-01-01 Capetti, F; Cagliero, C; Argenziano, M; Cavalli, R; Dianzani, C; Pavarino, M; Bicchi, C; Rubiolo, P; Sgorbini, B
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma
2024-01-01 Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M.
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas
2024-01-01 Dianzani, Chiara; Bozza, Annalisa; Bordano, Valentina; Cangemi, Luigi; Ferraris, Chiara; Foglietta, Federica; Monge, Chiara; Gallicchio, Margherita; Pizzimenti, Stefania; Marini, Elisabetta; Muntoni, Elisabetta; Valsania, Maria Carmen; Battaglia, Luigi
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
2023-01-01 Boggio E.; Gigliotti C.L.; Stoppa I.; Pantham D.; Sacchetti S.; Rolla R.; Grattarola M.; Monge C.; Pizzimenti S.; Dianzani U.; Dianzani C.; Battaglia L.
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
2023-01-01 Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S.
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma
2023-01-01 M.A.Cucci, M. Grattarola, C. Monge, A. Roetto, C. Dianzani, S.Pizzimenti
Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma
2023-01-01 Foglietta, Federica; Bozza, Annalisa; Ferraris, Chiara; Cangemi, Luigi; Bordano, Valentina; Serpe, Loredana; Martina, Katia; Lazzarato, Loretta; Pizzimenti, Stefania; Grattarola, Margherita; Cucci, Marie Angele; Dianzani, Chiara; Battaglia, Luigi
Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
2023-01-01 Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S.
Ultrasmall Solid-Lipid Nanoparticles via the Polysorbate Sorbitan Phase-Inversion Temperature Technique: A Promising Vehicle for Antioxidant Delivery into the Skin
2023-01-01 Della Sala, Francesca; Borzacchiello, Assunta; Dianzani, Chiara; Muntoni, Elisabetta; Argenziano, Monica; Capucchio, Maria Teresa; Valsania, Maria Carmen; Bozza, Annalisa; Garelli, Sara; Di Muro, Maria; Scorziello, Franco; Battaglia, Luigi
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
2022-01-01 Alves, Gustavo Ferreira; Stoppa, Ian; Aimaretti, Eleonora; Monge, Chiara; Mastrocola, Raffaella; Porchietto, Elisa; Einaudi, Giacomo; Collotta, Debora; Bertocchi, Ilaria; Boggio, Elena; Gigliotti, Casimiro Luca; Clemente, Nausicaa; Aragno, Manuela; Fernandes, Daniel; Cifani, Carlo; Thiemermann, Christoph; Dianzani, Chiara; Dianzani, Umberto; Collino, Massimo
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator
2022-01-01 Raineri D.; Cappellano G.; Vilardo B.; Maione F.; Clemente N.; Canciani E.; Boggio E.; Gigliotti C.L.; Monge C.; Dianzani C.; Boldorini R.; Dianzani U.; Chiocchetti A.
G protein–coupled receptor 21 in macrophages: An in vitro study
2022-01-01 Bordano V.; Kinsella G.K.; Cannito S.; Dianzani C.; Gigliotti C.L.; Stephens J.C.; Monge C.; Bocca C.; Rosa A.C.; Miglio G.; Dianzani U.; Findlay J.B.C.; Benetti E.
ICOSL Stimulation by ICOS‐Fc Accelerates Cutaneous Wound Healing In Vivo
2022-01-01 Stoppa I.; Gigliotti C.L.; Clemente N.; Pantham D.; Dianzani C.; Monge C.; Puricelli C.; Rolla R.; Sutti S.; Reno F.; Boldorini R.; Boggio E.; Dianzani U.
Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma
2022-01-01 Argenziano M.; Bessone F.; Dianzani C.; Cucci M.A.; Grattarola M.; Pizzimenti S.; Cavalli R.
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
2022-01-01 Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara
Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role
2021-01-01 Barrera G.; Cucci M.A.; Grattarola M.; Dianzani C.; Muzio G.; Pizzimenti S.
Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape
2021-01-01 luigi battaglia; Anna Scomparin; Chiara Dianzani; Paola Milla; Elisabetta Muntoni; Silvia Arpicco; Roberta Cavalli
Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies
2021-01-01 Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G.
A new bevacizumab carrier for intravitreal administration: Focus on stability
2021-01-01 Chirio D.; Peira E.; Sapino S.; Chindamo G.; Oliaro-bosso S.; Adinolfi S.; Dianzani C.; Baratta F.; Gallarate M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models | 2024 | Stoppa, Ian; Dianzani, Chiara; Clemente, Nausicaa; Bozza, Annalisa; Bordano, Valentina; Garelli, Sara; Cangemi, Luigi; Dianzani, Umberto; Battaglia, Luigi | |
| A New Blend of Litsea cubeba, Pinus mugo, and Cymbopogon winterianus Essential Oil Active as an Anti-tyrosinase Ingredient in Topical Formulations | 2024 | Capetti, F; Cagliero, C; Argenziano, M; Cavalli, R; Dianzani, C; Pavarino, M; Bicchi, C; Rubiolo, P; Sgorbini, B | |
| Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma | 2024 | Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M. | |
| Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas | 2024 | Dianzani, Chiara; Bozza, Annalisa; Bordano, Valentina; Cangemi, Luigi; Ferraris, Chiara; Foglietta, Federica; Monge, Chiara; Gallicchio, Margherita; Pizzimenti, Stefania; Marini, Elisabetta; Muntoni, Elisabetta; Valsania, Maria Carmen; Battaglia, Luigi | |
| Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications | 2023 | Boggio E.; Gigliotti C.L.; Stoppa I.; Pantham D.; Sacchetti S.; Rolla R.; Grattarola M.; Monge C.; Pizzimenti S.; Dianzani U.; Dianzani C.; Battaglia L. | |
| Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma | 2023 | Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S. | |
| Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma | 2023 | M.A.Cucci, M. Grattarola, C. Monge, A. Roetto, C. Dianzani, S.Pizzimenti | |
| Surface Functionalised Parenteral Nanoemulsions for Active and Homotypic Targeting to Melanoma | 2023 | Foglietta, Federica; Bozza, Annalisa; Ferraris, Chiara; Cangemi, Luigi; Bordano, Valentina; Serpe, Loredana; Martina, Katia; Lazzarato, Loretta; Pizzimenti, Stefania; Grattarola, Margherita; Cucci, Marie Angele; Dianzani, Chiara; Battaglia, Luigi | |
| Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle | 2023 | Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Ultrasmall Solid-Lipid Nanoparticles via the Polysorbate Sorbitan Phase-Inversion Temperature Technique: A Promising Vehicle for Antioxidant Delivery into the Skin | 2023 | Della Sala, Francesca; Borzacchiello, Assunta; Dianzani, Chiara; Muntoni, Elisabetta; Argenziano, Monica; Capucchio, Maria Teresa; Valsania, Maria Carmen; Bozza, Annalisa; Garelli, Sara; Di Muro, Maria; Scorziello, Franco; Battaglia, Luigi | |
| ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis | 2022 | Alves, Gustavo Ferreira; Stoppa, Ian; Aimaretti, Eleonora; Monge, Chiara; Mastrocola, Raffaella; Porchietto, Elisa; Einaudi, Giacomo; Collotta, Debora; Bertocchi, Ilaria; Boggio, Elena; Gigliotti, Casimiro Luca; Clemente, Nausicaa; Aragno, Manuela; Fernandes, Daniel; Cifani, Carlo; Thiemermann, Christoph; Dianzani, Chiara; Dianzani, Umberto; Collino, Massimo | |
| Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator | 2022 | Raineri D.; Cappellano G.; Vilardo B.; Maione F.; Clemente N.; Canciani E.; Boggio E.; Gigliotti C.L.; Monge C.; Dianzani C.; Boldorini R.; Dianzani U.; Chiocchetti A. | |
| G protein–coupled receptor 21 in macrophages: An in vitro study | 2022 | Bordano V.; Kinsella G.K.; Cannito S.; Dianzani C.; Gigliotti C.L.; Stephens J.C.; Monge C.; Bocca C.; Rosa A.C.; Miglio G.; Dianzani U.; Findlay J.B.C.; Benetti E. | |
| ICOSL Stimulation by ICOS‐Fc Accelerates Cutaneous Wound Healing In Vivo | 2022 | Stoppa I.; Gigliotti C.L.; Clemente N.; Pantham D.; Dianzani C.; Monge C.; Puricelli C.; Rolla R.; Sutti S.; Reno F.; Boldorini R.; Boggio E.; Dianzani U. | |
| Ultrasound-Responsive Nrf2-Targeting siRNA-Loaded Nanobubbles for Enhancing the Treatment of Melanoma | 2022 | Argenziano M.; Bessone F.; Dianzani C.; Cucci M.A.; Grattarola M.; Pizzimenti S.; Cavalli R. | |
| Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment | 2022 | Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara | |
| Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role | 2021 | Barrera G.; Cucci M.A.; Grattarola M.; Dianzani C.; Muzio G.; Pizzimenti S. | |
| Nanotechnology Addressing Cutaneous Melanoma: The Italian Landscape | 2021 | luigi battaglia; Anna Scomparin; Chiara Dianzani; Paola Milla; Elisabetta Muntoni; Silvia Arpicco; Roberta Cavalli | |
| Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies | 2021 | Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G. | |
| A new bevacizumab carrier for intravitreal administration: Focus on stability | 2021 | Chirio D.; Peira E.; Sapino S.; Chindamo G.; Oliaro-bosso S.; Adinolfi S.; Dianzani C.; Baratta F.; Gallarate M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile